3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl chloride

Catalog No. :
ACKOYQ972
CAS No. :
1181329-14-5
Molecular Formula :
C13H16BClO3
Molecular Weight :
266.53

IUPAC Name:3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl chloride

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$255.00Login to see priceInquiryInquiry
250mg98%$426.00Login to see priceInquiryInquiry
1g98%$851.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl chloride
IUPAC Name3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl chloride
MDL No.MFCD20489143
Molecular FormulaC13H16BClO3
Molecular Weight266.53
SMILESO=C(Cl)C1=CC=CC(B2OC(C)(C)C(C)(C)O2)=C1
InChI KeyPYUUKIHBIYIYIF-UHFFFAOYSA-N
Synonym3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoyl chloride;3-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl chloride;Benzoyl chloride, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1181329-14-5

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P321-P363-P405-P501

Synthetic Route by SureRoute

1. ACKOYQ972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEGVT713 route compound structure diagram
    ACEGVT713269409-73-6 In Stock
  2. Then
  3. ACKOYQ972 route product structure diagram
    ACKOYQ9721181329-14-5
Inquiry

2. ACKOYQ972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKOYQ972 route product structure diagram
    ACKOYQ9721181329-14-5
Inquiry

Comments (0)